FDC

** Shares of FDC FDC.NS fall 4.2% to 383.70 rupees

** Pharmaceuticals co says food safety officials from Maharashtra's Food & Drug Administration seized certain stock of 'Enerzal' product and picked up samples for examination

** Inspection and examination relates to misbranding of the product, co says

** Adds, final examination order is yet to be received in this regard

** FDC down ~9% YTD

(Reporting by Vijay Malkar)

(([email protected];))

June 4 (Reuters) - F D C Ltd FDC.NS:

• F D C LTD - FOOD SAFETY OFFICIALS VISITED COMPANY'S WAREHOUSE AT CHHATRAPATI SAMBHAJI NAGAR NAGPUR

• F D C - FOOD DRUG ADMINISTRATION MAHARASHTRA SEIZES 'ENERZAL' STOCK AND COLLECTS SAMPLES FOR EXAMINATION

• F D C LTD - BUSINESS OPERATION OF CO CONTINUES AS USUAL

Source text: ID:nBSE7pXWj6

Further company coverage: FDC.NS

(([email protected];))

May 27 (Reuters) - F D C Ltd FDC.NS:

• F D C MARCH-QUARTER CONSOL PROFIT 1.03 BILLION RUPEES

• F D C MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 5.85 BILLION RUPEES

Source text: ID:nnAZN4SYUNA

Further company coverage: FDC.NS

(([email protected];))

May 18 (Reuters) - F D C Ltd FDC.NS:

• F D C LTD - GRANTED ANDA APPROVAL BY U.S. FDA FOR CEFIXIME ORAL SUSPENSION

Source text: ID:nBSE6NS5zV

Further company coverage: FDC.NS

(([email protected];))

Feb 5 (Reuters) - F D C Ltd FDC.NS:

• DEC-QUARTER CONSOL NET PROFIT 283 MILLION RUPEES

• DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 4.65 BILLION RUPEES

• DIVIDEND 5 RUPEES PER SHARE

Source text: ID:nBSE7P0qfL

Further company coverage: FDC.NS

(([email protected];))

Jan 9 (Reuters) - F D C Ltd FDC.NS:

• RECEIVES ANDA APPROVAL FROM U.S. FDA FOR FLUCONAZOLE TABLETS

Source text: ID:nNSE8nqPlk

Further company coverage: FDC.NS

(([email protected];))

Dec 29 (Reuters) - F D C Ltd FDC.NS:

• RECEIVES TAX DEMAND ORDER WORTH 156.1 MILLION RUPEES

Source text: ID:nNSE4zT8MM

Further company coverage: FDC.NS

(([email protected];))

April 30 (Reuters) - F D C Ltd FDC.NS:

• F D C LTD - APPROVES EXPANSION OF LIQUID ORAL FACILITY AT SINNAR PLANT

• F D C LTD - PROPOSED CAPACITY EXPANSION TO 77,000 KILOLITRES PER ANNUM

• F D C LTD - INVESTMENT REQUIRED FOR EXPANSION APPROXIMATELY 1.40 BILLION RUPEES

Source text: ID:nBSE6dqq7c

Further company coverage: FDC.NS

(([email protected];;))

Feb 19 (Reuters) - F D C Ltd FDC.NS:

• F D C - GOT ORDER IMPOSING TAX, PENALTY 5.7 MILLION RUPEES EACH

Source text: ID:nBSE8Mxmw3

Further company coverage: FDC.NS

(([email protected];;))

Jan 31 (Reuters) - F D C Ltd FDC.NS:

• F D C - GOT TAX DEMAND ORDER FOR FOR 66.9 MILLION RUPEES, INTEREST OF 52.1 MILLION RUPEES

Source text: ID:nBSE9s9226

Further company coverage: FDC.NS

(([email protected];;))

Dec 18 (Reuters) - F D C Ltd FDC.NS:

• RECEIVES US FDA APPROVAL FOR CEFIXIME 400 MG TABLETS

Source text: ID:nBSE7Qd8Mh

Further company coverage: FDC.NS

(([email protected];;))

Nov 13 (Reuters) - F D C Ltd FDC.NS:

• GOT ESTABLISHMENT INSPECTION REPORT FROM US FDA WITH NO OBSERVATIONS FOR BADDI FACILITY

Further company coverage: FDC.NS

(([email protected];))

Nov 6 (Reuters) - F D C Ltd FDC.NS:

• F D C SEPT-QUARTER CONSOL NET PROFIT 720.4 MILLION RUPEES

• F D C SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 5.14 BILLION RUPEES

• F D C LTD - DIVIDEND 5 RUPEES PER SHARE

Source text: ID:nNSEbz8gXg

Further company coverage: FDC.NS

(([email protected];))

Aug 7 (Reuters) - F D C Ltd FDC.NS:

• F D C JUNE-QUARTER CONSOL NET PROFIT 1.19 BILLION RUPEES

• F D C JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 6.38 BILLION RUPEES

Further company coverage: FDC.NS

(([email protected];))

** Shares of FDC FDC.NS up as much as 9% to a record high of 471.95 rupees after Dec-quarter results

** Pharma and consumer healthcare firm says Q3 consolidated net profit surges 94.5%, revenue from operations up 11.9%

** Stock on track for fourth straight session of gains, which will be its longest winning streak in two months

** FDC up 17.6% YTD vs 3.5% gain in Nifty 500 index .NIFTY500

(Reporting by Rama Venkat in Bengaluru)

(([email protected]; https://twitter.com/ramavenkat0607;))

** Shares of drug maker FDC Ltd FDC.NS rise as much as 8.6% to record high of 432.80 rupees in heavy volume

** Reuters could not immediately verify the reason for the move

** Over 3.2 mln shares traded; stock's busiest session since Aug. 10, 2023, a day after FDC's Q1 results, share buyback plan

** Stock last up nearly 5%; It has risen 5% or more only on six occasions in 2023

** Stock rose ~46% in 2023, outperforming Nifty Pharma .NIPHARM index's ~34% rise

(Reporting by Nandan Mandayam in Bengaluru)

(([email protected]; Mobile: +91 9591011727;))

** India's pharmaceutical sector growth slowed to 2.9% year-on-year in November from 13.7% in October as volumes drop, data from All India Origin Chemists and Distributors (AIOCD) showed

** Volumes in November down 4.5% year-on-year after rising 5% in the previous month

** Dermatology and opthalmology segments witness fall in sales while anti-infectives, cardiac, respiratory segments see rise in sales in November

** Eris Lifesciences ERIS.NS, Cipla CIPL.NS, Torrent Pharmaceuticals TORP.NS, Sun Pharmaceutical Industries SUN.NS and Glenmark Pharmaceuticals GLEN.NS see sales uptick of 7% to 11%, outperforming the Indian pharma market

** FDC FDC.NS, Alembic Pharma ALEM.NS, GlaxoSmithKline Pharmaceuticals GLAX.NS and Mankind Pharma MNKI.NS underperform the industry, in terms of November sales

** Pfizer PFIZ.NS sees sales decline of 11.9% while Sanofi India SANO.NS posts 5.7% monthly sales drop

** Nifty pharma index .NIPHARM down 0.9% on the day, dragged by 5% drop in Dr. Reddy's Laboratories REDY.NS on U.S. drug regulator's observations on the drug maker's facility at Hyderabad

** Pharma index up 27% in 2023 so far, compared with 16% rise in Nifty 50 index .NSEI

(Reporting by Bharath Rajeswaran in Bengaluru)

(([email protected]; +91 9769003463;))

Nov 8 (Reuters) - F D C Ltd FDC.NS:

• INDIA'S F D C LTD SEPT-QUARTER CONSOL NET PROFIT 698.2 MILLION RUPEES VERSUS PROFIT 518.4 MILLION RUPEES

• F D C LTD SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 4.86 BILLION RUPEES VERSUS 4.45 BILLION RUPEES

Source text for Eikon: [ID:]

Further company coverage: FDC.NS

(([email protected];))

Adds Lindt comment

By Dominique Vidalon

PARIS, Sept 14 (Reuters) - French supermarket chain Carrefour CARR.PA has slapped price warnings on products from Lindt chocolates to Lipton Ice Tea to pressure top consumer goods suppliers Nestle, PepsiCo and Unilever to reduce inflation ahead of much-anticipated contract talks.

Carrefour is putting stickers on products that have shrunk in size but cost more even after raw materials prices have eased, to rally consumer support as retailers prepare to face the world's biggest brands in negotiations due to start soon and end by Oct. 15.

"Obviously, the aim in stigmatising these products is to be able to tell manufacturers to rethink their pricing policy," Stefen Bompais, director of client communications at Carrefour, said in an interview.

Carrefour CEO Alexandre Bompard, who also heads retail industry lobby group FDC, has repeatedly said consumer goods companies are not cooperating in efforts to cut the price of thousands of staples despite a fall in the cost of raw materials.

In this he is backed by Finance Minister Bruno Le Maire, who in June summoned 75 big retailers and consumer groups to his ministry urging them to cut prices. After a new round of meetings last month, Le Maire said Unilever, Nestle and PepsiCo were among companies not toeing the line on prices.

Since Monday, Carrefour has marked 26 products in its stores in France with labels reading, "This product has seen its volume or weight fall and the effective price by the supplier rise."

For example, Carrefour said a bottle of sugar-free peach-flavoured Lipton Ice Tea, produced by PepsiCo, shrank to 1.25 litres (0.33 gallon) from 1.5 litres, resulting in a 40% effective increase in the price per litre.

Guigoz infant formula produced by Nestle went from 900 grams (31.75 oz) to 830 grams, while Unilever's Viennetta ice-cream cake shrank to 320 grams from 350 grams.

Lindt's "chocolat au lait extra fin" was one of three of the Swiss chocolatier's products named in the list.

"Lindt & Sprüngli increased its prices group wide on average by 9.3% in line with local cost structures," a company spokesperson told Reuters. "We have made a concerted effort to compensate for increased costs by increasing efficiency as much as possible. Therefore, we have only passed on the costs we could not absorb ourselves in the form of price increases to our customers."

PepsiCo did not respond to a request for comment. Nestle and Unilever declined to comment.

Consumer groups say "shrinkflation" is a widespread practice, which supermarkets like Carrefour are also guilty of in their private label products.

France, like other European countries, has been trying for months to ease consumer pain in the face of a surge in the cost of living, strong-arming big business to freeze or cut food and transport prices - with mixed results.

The shrinkflation warnings are in all French Carrefour stores, and will last until the targeted suppliers agree to price cuts, Bompais said. The retailer could extend warnings to other goods, but does not plan to extend the initiative to other countries.

Le Maire said last month consumer goods companies and retailers had agreed to bring forward annual price negotiations - which would normally have taken place next year - to September. The talks will result in price cuts from January, he said.

(Reporting by Dominique Vidalon in Paris, Richa Naidu in London; Writing by Helen Reid; Editing by Silvia Aloisi, Richard Chang and David Evans)

(([email protected]; +44 7584 155 200 ;))

** Shares of FDC Ltd FDC.NS rise as much as 10.2% to a record high of 429 rupees

** Co on Wednesday reported its consolidated net profit jumped 55.3% to 1.1 bln rupees ($13.28 mln), rev from ops up 8.3% Y/Y

** Adds, approved acquisition of additional 7% stake in unit FDC SA; also approved buyback for up to 3.1 mln shares at 500 rupees apiece

** More than 2.4 mln shares change hands by 09:55 a.m. IST vs 3.8x 30-day avg of 639,891 shares

** Analysts covering the stock on average have a "strong buy" rating; median PT is 350 rupees - Refinitiv data

** Stock up 43.7% YTD up to last close

($1 = 82.8200 Indian rupees)

(Reporting by Ashna Teresa Britto in Bengaluru)

(([email protected] ; ( +91 8078332441))

Aug 9 (Reuters) - F D C Ltd FDC.NS:

• F D C LTD - RE-APPOINTS MOHAN A. CHANDAVARKAR AS MD

• F D C LTD - RE-APPOINTS NANDAN M. CHANDAVARKAR AS JOINT MD

• INDIA'S F D C LTD JUNE-QUARTER CONSOL NET PROFIT 1.1 BILLION RUPEES VERSUS PROFIT 707.4 MILLION RUPEES

• F D C LTD JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 5.36 BILLION RUPEES VERSUS 4.95 BILLION RUPEES

Source text for Eikon: ID:nBSE6yBhQC

Further company coverage: FDC.NS

(([email protected];))

Aug 3 (Reuters) - F D C Ltd FDC.NS:

• F D C LTD - TO CONSIDER PROPOSAL FOR BUYBACK OF SHARES OF COMPANY

Source text for Eikon: ID:nBSECXHwH

Further company coverage: FDC.NS

(([email protected];))

June 15 (Reuters) - F D C Ltd FDC.NS:

• F D C LTD- FDA INSPECTION AT COMPANY'S MANUFACTURING FACILITY LOCATED AT WALUJ, AURANGABAD

• F D C LTD- RECEIPT OF ESTABLISHMENT INSPECTION REPORT (EIR) WITH NO ACTION INDICATED

Source text for Eikon: ID:nBSE4j7NPX

Further company coverage: FDC.NS

(([email protected];))

May 25 (Reuters) - F D C Ltd FDC.NS:

• MARCH-QUARTER CONSOL NET PROFIT 307.1 MILLION RUPEES VERSUS 104.4 MILLION RUPEES

• MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.35 BILLION RUPEES VERSUS 3.41 BILLION RUPEES

Source text for Eikon: [ID:]

Further company coverage: FDC.NS

(([email protected];))